Floatz logo

Therapeutic Asset Ratings

197 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Trop2-Car-Nk Cells
Neoplasm
M.D. Anderson Cancer CenterP1C (37)
TX103 CAR-T
Neoplasm
Tcelltech Inc.P1C (37)
Tyra-430
Neoplasm
Tyra Biosciences, IncP1C (37)
Val-413
Neoplasm
Valent Technologies, LLCP1C (37)
Vrp-Encapsulated Sarna Encoding Il-12
Neoplasm
VLP TherapeuticsP1C (37)
xb371
Neoplasm
ExelixisP1C (37)
Xmab662
Neoplasm
Xencor, Inc.P1C (37)
Zimberelimab
Neoplasm
Compugen LtdP1C (37)
zl-6201
Neoplasm
Zai Lab (Shanghai) Co., Ltd.P1C (37)
il-12
Neoplasm
Memorial Sloan Kettering Cancer CenterP1C (36)
ABO2109
Neoplasm
Suzhou Abogen Biosciences Co., Ltd.Early P1C (34)
il-15 enhanced engineered nk cells
Neoplasm
Genovn Therapeutics (Suzhou) Co., Ltd.Early P1C (34)
rt01-89zr
Neoplasm
Nanolattix Biotechnology Co., Ltd.Early P1C (34)
Tisagenlecleucel
Solid Tumors
National Cancer Institute (NCI)D (28)
Atb-320
Neoplasm
AutotelicbioP1NR (0)
Hemay5087
Neoplasm
Ganzhou Hemay Pharmaceutical Co., LtdP1NR (0)
Kivu-305
Neoplasm
Kivu Bioscience Inc.P1NR (0)
Lutetium [177Lu]-Fap-75
Neoplasm
Fudan UniversityP1NR (0)
Snh-118110 Soft Capsules
Neoplasm
ScinnoHub Pharmaceutical Co., Ltd.P1NR (0)
Th-Cart-027
Neoplasm
Shanghai Tongji Hospital, Tongji University School of MedicineEarly P1NR (0)
ky-0301
Neoplasm
Novatim Immune Therapeutics (Zhejiang) Co., Ltd.P1/2NR (0)
rc288 for
Neoplasm
RemeGen Co., Ltd.P1/2NR (0)
Showing 176 to 197 of 197 assets
PreviousPage 8 of 8Next